title: What's new in pediatric dermatology?: part II. Treatment.
abstract: The field of pediatric dermatology has been rich in new developments. Part II of this continuing medical education article will focus on new therapeutic modalities for several entities encountered in pediatric dermatology. The treatment of atopic dermatitis, exciting advances in the use of propranolol and other beta-blockers for the use of infantile hemangiomas, the use of rapamycin for vascular anomalies, the use of biologics in children, the central nervous system risks of general anesthesia in young children, side effects in the use of isotretinoin, the treatment of tinea capitis, treatment of herpes simplex infections, and the use of technologies such as texting and social media in medicine will be discussed.
authors.affiliation: Department of Dermatology, Geisinger Medical Center, Danville, Pennsylvania 17822-5206, USA. hpride@geisinger.edu
authors.forename: Howard B
authors.initials: HB
authors.lastname: Pride
authors.forename: Megha
authors.initials: M
authors.lastname: Tollefson
authors.forename: Robert
authors.initials: R
authors.lastname: Silverman
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000628:therapy*; D003880:Dermatology / Q000639:trends; D006391:Hemangioma / Q000188:drug therapy; D006801:Humans; D020407:Internet; D011433:Propranolol / Q000627:therapeutic use; D012871:Skin Diseases / Q000628:therapy*; D061108:Social Media; D014006:Tinea Capitis / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D014665:Vasodilator Agents; D011433:Propranolol; D000212:Acyclovir